Updated Epidemiology of Gastric Cancer in Asia: Decreased Incidence but Still a Big Challenge
- PMID: 37174105
- PMCID: PMC10177574
- DOI: 10.3390/cancers15092639
Updated Epidemiology of Gastric Cancer in Asia: Decreased Incidence but Still a Big Challenge
Abstract
Despite the decline in incidence and mortality rates, gastric cancer (GC) is the fifth leading cause of cancer deaths worldwide. The incidence and mortality of GC are exceptionally high in Asia due to high H. pylori infection, dietary habits, smoking behaviors, and heavy alcohol consumption. In Asia, males are more susceptible to developing GC than females. Variations in H. pylori strains and prevalence rates may contribute to the differences in incidence and mortality rates across Asian countries. Large-scale H. pylori eradication was one of the effective ways to reduce GC incidences. Treatment methods and clinical trials have evolved, but the 5-year survival rate of advanced GC is still low. Efforts should be put towards large-scale screening and early diagnosis, precision medicine, and deep mechanism studies on the interplay of GC cells and microenvironments for dealing with peritoneal metastasis and prolonging patients' survival.
Keywords: H. pylori; gastric cancer; incidence; mortality; targeted therapy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures










Similar articles
-
Characteristics of gastric cancer in Asia.World J Gastroenterol. 2014 Apr 28;20(16):4483-90. doi: 10.3748/wjg.v20.i16.4483. World J Gastroenterol. 2014. PMID: 24782601 Free PMC article. Review.
-
Chemoprevention of gastric cancer development after Helicobacter pylori eradication therapy in an East Asian population: Meta-analysis.World J Gastroenterol. 2020 Apr 21;26(15):1820-1840. doi: 10.3748/wjg.v26.i15.1820. World J Gastroenterol. 2020. PMID: 32351296 Free PMC article.
-
Gastric cancer: Epidemiology, risk factors and prevention strategies.Chin J Cancer Res. 2020 Dec 31;32(6):695-704. doi: 10.21147/j.issn.1000-9604.2020.06.03. Chin J Cancer Res. 2020. PMID: 33446993 Free PMC article.
-
Estimation of gastric cancer burden attributable to Helicobacter pylori infection in Asia.J Public Health (Oxf). 2023 Mar 14;45(1):40-46. doi: 10.1093/pubmed/fdab410. J Public Health (Oxf). 2023. PMID: 35137200
-
Review: Prevention and management of gastric cancer.Helicobacter. 2020 Sep;25 Suppl 1:e12740. doi: 10.1111/hel.12740. Helicobacter. 2020. PMID: 32918347 Review.
Cited by
-
Feasibility and Safety of Early Oral Feeding After Radical Gastrectomy in Patients With Gastric Carcinoma: A Systematic Review.Cureus. 2024 Aug 8;16(8):e66463. doi: 10.7759/cureus.66463. eCollection 2024 Aug. Cureus. 2024. PMID: 39247003 Free PMC article. Review.
-
Metastatic Lymph Node 64 (MLN64) Expression in Gastric Cancer: The Clinical and Molecular Implications in Drug Resistance.Cancer Genomics Proteomics. 2024 Jan-Feb;21(1):30-40. doi: 10.21873/cgp.20427. Cancer Genomics Proteomics. 2024. PMID: 38151289 Free PMC article.
-
A novel m6A/m5C/m1A/m7G-related classification and risk signature predicts prognosis and reveals immunotherapy inclination in gastric cancer.Transl Cancer Res. 2024 Jul 31;13(7):3285-3298. doi: 10.21037/tcr-23-2325. Epub 2024 Jul 26. Transl Cancer Res. 2024. PMID: 39145046 Free PMC article.
-
PCAT19: the role in cancer pathogenesis and beyond.Front Cell Dev Biol. 2024 Dec 18;12:1435717. doi: 10.3389/fcell.2024.1435717. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39744012 Free PMC article. Review.
-
Heterogeneous Cellular Response of Primary and Metastatic Human Gastric Adenocarcinoma Cell Lines to Magnoflorine and Its Additive Interaction with Docetaxel.Int J Mol Sci. 2023 Oct 24;24(21):15511. doi: 10.3390/ijms242115511. Int J Mol Sci. 2023. PMID: 37958494 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous